UCSD Receives $4.7M in Funding to Explore CBD as a Treatment for Extreme Cases of Autism

The University of California San Diego, one of the most prestigious colleges in the sunshine state, has been granted $4.7 million dollars in private donations to study Cananbidiol (CBD) as a possible treatment for those with severe autism.

UCSD will study whether or not Cannabidiol oil can be an effective treatment to those who have severe autism, including severe seizures, self injury, and anxiety caused from autism. Severe autism currently effects 3.5 million Americans a year.

The UCSD Medicinal Cannabis Research Center will conduct clinical trials with a group of autistic children, ages 8-12, living in Southern California. During administration fo the CBD oil, the children will undergo behavioral testing, MRI scans, and electroencephalograms.

Federal law forces those involved in seeking relief from CBD products to operate within an apparent “grey area” of the marketplace. Since the federal government labels all cannabinoids a Schedule 1 drug, which in their opinion has no medicinal value, very little government money goes to the research of cannabis and industrial hemp as a medicine.

The validation of these plants as a possible medication for those in need strictly depends on donations like those from  the Ray & Tye Noorda Foundation, which will hopefully give medical claims legitimacy. The research conducted by Universities across the country is vital to treating the numerous ailments and diseases that the people of the U.S. suffer from.

Leave a Comment